What drugs does AARXION ANDA HLDING make?

AARXION ANDA HLDING has 6 FDA-approved drugs.

What therapeutic areas does AARXION ANDA HLDING focus on?

AARXION ANDA HLDING focuses primarily on Immunology and Gastroenterology.

← Back

Data updated: Mar 10, 2026

AARXION ANDA HLDING

ImmunologyGastroenterology

Specialty

AARXION ANDA HLDING is a specialty pharmaceutical company focused on Immunology, Gastroenterology.

1981

Since

Drugs

Trials

Approved (2yr)

Key Drugs

No active drugs

Recent Activity

OXAPROZIN 2026-01-22

Labeling

EPLERENONE 2025-12-04

Labeling

METFORMIN HYDROCHLORIDE 2025-11-10

Manufacturing (CMC)

METFORMIN HYDROCHLORIDE 2025-06-24

Labeling

METFORMIN HYDROCHLORIDE 2025-06-24

Labeling

BALSALAZIDE DISODIUM 2025-06-23

Labeling

BALSALAZIDE DISODIUM 2025-06-23

Labeling

METFORMIN HYDROCHLORIDE 2025-04-14

BALSALAZIDE DISODIUM 2025-04-03

NEOMYCIN SULFATE 2025-03-27

Labeling

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 50%

2 drugs

Gastroenterology 50%

2 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

Pfizer big-pharma

Immunology, Gastroenterology

Bristol-Myers Squibb big-pharma

Immunology, Gastroenterology

BAUSCH specialty

Immunology, Gastroenterology

Takeda big-pharma

Immunology, Gastroenterology

Gilead Sciences biotech

Immunology, Gastroenterology

AARXION ANDA HLDING

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (6)

Active (4)

Discontinued (2)

Company Info